Ischemia-modified albumin and fibulin-5 as diagnostic and prognostic markers for acute cerebrovascular disease

Table 1 Clinical characteristics of cerebrovascular stroke patients and control group

Clinical characteristics	Stroke patients (n = 100)	Control group (n = 75)	t test	P value
Clinical characteristics	Mean ± SD	Mean ± SD	t test	P value
Age [years]: mean ± SD	51.48 ± 11.72	49.64 ± 8.91	t = 1.14	0.258
Sex: (No. [%])
Males	58 [58.0]	55 [73.3]	χ² = 5.49	0.064
Females	42 [42.0]	20 [26.7]	χ² = 5.49	0.064
BMI (kg/m²)	28.38 ± 5.89	24.72 ± 4.66	4.44	< 0.001*
NIHSS	14.24 ± 5.17	-	-	-
GCS	12.10 ± 2.54	-	-	-
	No. (%)	No. (%)	χ²
Smoking	42 (42.0)	22 (29.3)	2.96	0.085
Alcoholic	4 (4.0)	0	3.07	0.080
Hypertension	66 (66.0)	30 (40.0)	11.70	0.001*
Diabetes mellitus	28 (28.0)	16 (21.3)	1.01	0.314
Hyperuricemia	30 (30.0)	61 (81.3)	2.73	0.087
AF	18 (18.0)	4 (5.0)	6.26	0.012*
Carotid artery stenosis	52 (52.0)	18 (24.0)	14.00	< 0.001*

AF atrial fibrillation, BMI body mass index, GCS Glasgow Coma Scale, NIHSS National Institute of Health Stroke Scale, SD standard deviation, χ² chi-square test
(*) means statistically significant